Research suggests that compared to vaginally-born children, cesarean-born children may have a higher risk of infection-related hospitalization for up to five years of age.
The patient was treated under an emergency IND filed by a qualified Investigator and approved by the US FDA, according to the manufacturer Vero Biotech.
New devices are continuing the life-saving impact of bubble CPAP technology, which, since 1973, has saved thousands of newborns with severe respiratory illnesses.
Researchers have shown how microbial communities are linked to each other across the body and how these networks are associated with susceptibility to respiratory infections in babies.
Read More
Dräger has received FDA clearance for its Seattle PAP (Positive Airway Pressure) plus system, which uses bubble CPAP technology to treat premature infants with respiratory distress.
Read More
A 6-month-old girl died from a fatal dose of allergy medicine at a daycare in North...
Read More
According to a national poll, 41% of parents may seek a new provider because of unvaccinated...
Read More
Worried about peanut allergies in children? A practice article in CMAJ (Canadian Medical...
Read More
Infants born to women exposed to high levels of air pollution in the week before delivery are more...
Read More
According to the FDA, a Class I recall has been issued for Teleflex’s Neonatal ConchaSmart Breathing Circuit with Dual Heated Limb and ConchaSmart Column.
Read More
An online intervention with real-time information on locally circulating viruses may reduce mothers’ intentions to visit their primary care doctor to treat infants’ respiratory tract infections.
Read More
Researchers in Germany have successfully developed a new protocol for identifying neonatal patients with bronchopulmonary dysplasia by the use of magnetic resonance imaging (MRI), according to a study published in Thorax.
Read More
In children with asthma, dietary omega-3 was tied to less severe asthma and fewer symptoms, while omega-6 was tied to more severe asthma and more symptoms.
Read More
New research suggests that respiratory syncytial virus (RSV) burden for infants under age 2 was 1.5-fold greater than previously believed.
Read MoreBabies born very prematurely are more likely to have Ureaplasma bacteria, which increases their mortality risk and likelihood of bronchopulmonary dysplasia.
Read More